Seeing Is Believing

Currently out of the existing stock ratings of Matt Borsch, 78 are a BUY (57.35%), 55 are a HOLD (40.44%), 3 are a SELL (2.21%).
Analyst Matt Borsch, carries an average stock price target met ratio of 80.61% that have a potential upside of 17.74% achieved within 261 days. Previously, Matt Borsch worked at BMO, GOLDMAN SACHS.
Matt Borsch’s has documented 272 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MD, Mednax at 10-Aug-2022.
Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for HCA (HCA HOLDINGS) at 7/13/2020. The price target of $100 was fulfilled within 2 days with a profit of $6.05 (6.44%) receiving and performance score of 32.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Apr-2025
$39
$10.64 (37.52%)
$38
1 months 13 days ago
(30-Jul-2026)
4/7 (57.14%)
$10.86 (38.59%)
135
Hold Since 03-Mar-2026
$32
$3.64 (12.83%)
$25
1 months 13 days ago
(30-Jul-2026)
10/19 (52.63%)
$3.86 (13.72%)
157
Buy Since 07-Jan-2025
$36
$7.64 (26.94%)
$30
1 months 29 days ago
(14-Jul-2026)
3/5 (60%)
$4.4 (13.92%)
37
Buy Since 05-Feb-2025
$40
$11.64 (41.04%)
$25
1 months 29 days ago
(14-Jul-2026)
6/11 (54.55%)
$8.4 (26.58%)
211
Buy Since 31-Jul-2023
$39
$10.64 (37.52%)
$31
2 months 3 days ago
(09-Jul-2026)
5/8 (62.5%)
$7.6 (24.20%)
187